Article in European psychiatry : the journal of the Association of European Psychiatrists, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
33 authors.
César González-BlanchMental Health Centre, University Hospital Marqués de Valdecilla, Santander, Spain.ORCID 0000-0002-3181-4731
Esther PousaDepartment of Psychiatry, Hospital de la Santa Creu i Sant Pau, Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain.ORCID 0000-0003-4423-6739
Pablo Reguera-PozueloDepartment of Psychiatry, School of Medicine, University of Seville, Seville, Spain.
Alfonso Gutiérrez-ZotesCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.ORCID 0000-0002-4858-1487
Roberto Rodriguez-JimenezCIBERSAM-ISCIII (Biomedical Research Networking Centre in Mental Health), Spain.ORCID 0000-0003-2251-7249
Manuel Del-Castillo-SerranoCIBERSAM-ISCIII (Biomedical Research Networking Centre in Mental Health), Spain.
Ana González-PintoBIORABA, Department of Psychiatry, Hospital Universitario de Álava, CIBERSAM, UPV/EHU, Vitoria, Spain.ORCID 0000-0002-2568-5179
Guillermo Cano-EscaleraBIORABA, Department of Psychiatry, Hospital Universitario de Álava, CIBERSAM, UPV/EHU, Vitoria, Spain.ORCID 0009-0005-1421-5496
Marta ZubiaBIORABA, Department of Psychiatry, Hospital Universitario de Álava, CIBERSAM, UPV/EHU, Vitoria, Spain.
Joan Vicent Sánchez-OrtíCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.ORCID 0000-0002-8209-6688
Patricia Correa-GhisaysCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.ORCID 0000-0002-1752-7349
Vicent Balanzá-MartínezCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.ORCID 0000-0001-7772-7396
Raquel López-CarrileroCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.ORCID 0000-0003-4110-794X
Teresa Bobes-BascaránCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.ORCID 0000-0002-5279-504X
Ana CatalánCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.ORCID 0000-0002-0418-7904
Claudia AymerichCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.ORCID 0000-0003-0040-1608
Daniel GuinartInstitut de Salut Mental, Hospital del Mar, Barcelona, Spain.ORCID 0000-0001-5078-6716
Elisabet VilellaCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.ORCID 0000-0002-1887-5919
Leticia García-ÁlvarezCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.ORCID 0000-0001-9482-2993
Susana OchoaCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.ORCID 0000-0001-6792-1080
Salvador MiretCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.ORCID 0000-0002-2275-8272
Cristina FalipDepartment of Psychiatry, Mental Health and Addictions, Hospital Universitari Santa Maria, Lleida, Spain.
Rafael Fernández-MartínezDepartment of Psychiatry, Hospital Álvaro Cunqueiro, Servicio Galego de Saúde (SERGAS), Vigo, Spain.ORCID 0000-0002-0842-898X
Ignacio García-CabezaDepartment of Psychiatry, HGU Gregorio Marañón, Madrid, Spain.ORCID 0000-0002-7542-4321
Carlos Campos-RodriguezMental Health Research Group, Hospital del Mar Research Institute, CIBERSAM, Barcelona, Spain.ORCID 0000-0002-6982-1339
Josep Maria CrosasMental Health Group, Consorci Corporació Sanitària Parc Taulí - I3PT - CIBERSAM. Sabadell, Barcelona, Spain.
Jesus CoboDepartament de Psiquiatria i Medicina Legal, Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID 0000-0002-2032-9343
Helena Pardina-TornerMental Health Research Group, Hospital del Mar Research Institute, CIBERSAM, Barcelona, Spain.
Salvador Perona-GarcelánDepartment of Psychiatry, University Hospital Virgen del Rocio, Andalusian Health Service, Seville, Spain.
Ángel Yorca-RuizIDIVAL, Valdecilla Biomedical Research Institute, Santander, Spain.ORCID 0000-0002-2701-3755
Víctor Ortiz-García de la FozIDIVAL, Valdecilla Biomedical Research Institute, Santander, Spain.ORCID 0000-0002-0627-1827
Rosa Ayesa-ArriolaIDIVAL, Valdecilla Biomedical Research Institute, Santander, Spain.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
backgroundCognitive impairment is central to psychosis and strongly linked to functional outcomes. The Brief Assessment of Cognition (BAC) app is a tablet-based, automated tool for assessing key cognitive domains but has not been validated in Spanish-speaking populations or across illness stages.
methodsA total of 402 participants (117 with first-episode psychosis [FEP], 125 with schizophrenia, and 160 controls) completed the BAC app along with clinical and functional assessments. We evaluated internal consistency, group differences, convergent and discriminant validity, and the effects of sex, age, and education. Normative percentiles were derived from controls.
resultsThe BAC app showed good internal consistency across groups (α = 0.76-0.87) and effectively differentiated individuals with psychosis from controls (area under the curve [AUC] = 0.862), with performance declining from controls to FEP to schizophrenia. Discrimination between FEP and schizophrenia was limited (AUC = 0.649). BAC App correlated positively with estimated intelligence quotient and functional capacity, and negatively with symptom severity, particularly in FEP. Performance varied by age, sex, and education, supporting the need for stratified normative data.
conclusionsThe BAC app showed strong reliability and validity for cognitive assessment in Spanish-speaking individuals with psychosis. Its brevity, automated scoring, and normative data support its clinical and research applications for cognitive screening, monitoring, and treatment evaluation.
Indexed as
Cognitive DysfunctionMobile ApplicationsNeuropsychological TestsPsychotic DisordersSchizophreniaAdolescentAdultCase-Control StudiesFemaleHumansMaleMiddle AgedPsychometricsReproducibility of ResultsYoung AdultBAC appcognitive assessmentfirst-episode psychosisnormative dataschizophreniavalidation study
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Validation and normative data for the BAC app in Spanish-speaking individuals with psychosis and healthy controls. · full record | OpenQuestion